Últimas noticias sobre  (OTC:MSPQL) Bolsa

HC Wainwright &amp; Co. analyst Andrew Fein reiterates AC Immune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIU#NASDAQ">ACIU</a>) with a Buy and maintains $16 price target.

News

Price Target

Reiteration

Analyst Ratings

ACIU

HC Wainwright & Co. Reiterates Buy on AC Immune, Maintains $16 Price Target

Needham analyst Mayank Tandon maintains Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) with a Buy and raises the price target from $125 to $145.

AGYS

Needham Maintains Buy on Agilysys, Raises Price Target to $145

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Annexon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANNX#NASDAQ">ANNX</a>) with a Buy and maintains $30 price target.

ANNX

HC Wainwright & Co. Reiterates Buy on Annexon, Maintains $30 Price Target

VEON

VEON Says It Has Completed The Registration Of And Received The Commercial License For Its Branch Office In Dubai International Finance Centre

HC Wainwright &amp; Co. analyst Andrew Fein reiterates TScan Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRX#NASDAQ">TCRX</a>) with a Buy and maintains $15 price target.

TCRX

HC Wainwright & Co. Reiterates Buy on TScan Therapeutics, Maintains $15 Price Target

Spectrum Brands Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPB#NYSE">SPB</a>) reported quarterly earnings of $0.97 per share which missed the analyst consensus estimate of $1.07 by 9.35 percent. This is a 13.39 percent decrease over earnings of $1.12 per share from the same period last year. The company reported quarterly sales of $773.70 million which beat the analyst consensus estimate of $747.51 million by 3.50 percent. This is a 4.46 percent increase over sales of $740.70 million the same period last year.

Spectrum Brands Holdings Q4 Adj $0.97 Misses $1.07 Estimate, Sales $773.70M Beat $747.51M Estimate

Earnings

BABA

Alibaba Q2 Cloud Intelligence Group Revenue $4.22B (+7% YoY), International Digital Commerce $4.51B (+29% YoY), Cainiao Smart Logistics Revenue $3.51B (+8% YoY)

The company plans to issue a special one-time dividend of 5 million shares of its Class B Common Stock to all holders of its Class A Common Stock and the Series C Convertible Preferred Stock on an as-converted basis. The record date for the Distribution is November 29, 2024.

Dividends

GPUS

Hyperscale Data Declares Special Dividend Of Class B Common Stock

HC Wainwright &amp; Co. analyst Andrew Fein reiterates Blueprint Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) with a Buy and maintains $135 price target.

BPMC

HC Wainwright & Co. Reiterates Buy on Blueprint Medicines, Maintains $135 Price Target

Alibaba Group Holding Q2 Adj EPADS $2.15, Sales $33.70B Beat $33.47B Estimate

HC Wainwright &amp; Co. analyst Andrew Fein reiterates I-MAB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMAB#NASDAQ">IMAB</a>) with a Buy and maintains $8 price target.

IMAB

HC Wainwright & Co. Reiterates Buy on I-MAB, Maintains $8 Price Target

Needham analyst Charles Shi maintains Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) with a Buy and lowers the price target from $240 to $225.

AMAT

Needham Maintains Buy on Applied Mat, Lowers Price Target to $225

<a href="https://www.bloomberg.com/news/articles/2024-11-15/alibaba-is-said-to-consider-offering-5-billion-of-bonds?sref=y3YMCJ4e" title="https://www.bloomberg.com/news/articles/2024-11-15/alibaba-is-said-to-consider-offering-5-billion-of-bonds?sref=y3YMCJ4e">https://www.bloomberg.com/news/articles/2024-11-15/alibaba-is-said-to-consider-offering-5-billion-of-bonds?sref=y3YMCJ4e</a>

Bonds

Offerings

Markets

Bloomberg Reported Earlier, Alibaba Is Said To Consider Offering $5B Of Bonds

HC Wainwright &amp; Co. analyst Robert Burns reiterates ArriVent BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVBP#NASDAQ">AVBP</a>) with a Buy and maintains $36 price target.

AVBP

HC Wainwright & Co. Reiterates Buy on ArriVent BioPharma, Maintains $36 Price Target

On Thursday, Nov. 14, U.S. markets ended lower after Fed Chair Jerome Powell dampened hopes for an interest rate cut, citing steady economic growth, a strong job market, and persistent inflation. Traders reduced bets on a December cut, leading to declines in the Dow, S&amp;P 500, and Nasdaq.
Powell&#8217;s remarks followed data showing a rise in producer prices for October, slightly higher than expected.
Related: <a target="_blank" href="https://www.benzinga.com/news/treasuries/24/11/41993899/powells-hawkish-remarks-shake-markets-stocks-fall-dollar-rockets-bitcoin-dips" rel="noreferrer noopener">Powell&#8217;s Hawkish Remarks Shake Markets: Stocks Fall, Dollar Rockets, Bitcoin Dips</a>
Economic data showed that U.S. jobless claims fell by 4,000 to 217,000 for the week ending Nov. 9, beating estimates of 223,000. Producer prices increased by 0.2% in October, matching market expectations after a revised 0.1% rise in September.
The majority of S&amp;P 500 sectors fell, led by consumer discretionary, industrials, and healthcare. However, tech and energy stocks ended higher.
The Dow Jones Industrial Average was down 0.47% and closed at 43,750.86, the S&amp;P 500 declined 0.50% to 5,949.17, and the Nasdaq Composite slid 0.64% to finish at 19,107.65.
Asia Markets Today
<ul>
<li>On Friday, Japan&#8217;s Nikkei 225 declined 0.35% and ended the session at 38,637.50, led by gains in the Warehousing, Shipbuilding, and Trading sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 rose 0.74% and ended the day at 8,285.20, led by gains in the Utilities, Gold, and Financials sectors.</li>
<li>India Markets were closed for the Guru Nanak Jayanti holiday.</li>
<li>China&#8217;s Shanghai Composite declined 1.45% to close at 3,330.73, and the Shenzhen CSI 300 fell 1.75%, finishing the day at 3,968.83.</li>
<li>Hong Kong&#8217;s Hang Seng slipped 0.09% and closed the session at 19,426.34.</li>
</ul>
Eurozone at 05:30 AM ET
<ul>
<li>The European STOXX 50 index was down 0.23%.</li>
<li>Germany&#8217;s DAX gained 0.14%.</li>
<li>France&#8217;s CAC fell0.04%.</li>
<li>UK&#8217;s FTSE 100 index traded higher by 0.02%.</li>
<li>European stocks were mixed after weak U.K. growth data, higher French inflation, and hawkish Fed remarks.</li>
</ul>
Commodities at 05:30 AM ET
<ul>
<li>Crude Oil WTI was trading lower by 1.35% at $67.78/bbl, and Brent was down 1.28% at $71.63/bbl.</li>
<li>Oil prices declined, heading for a weekly loss amid concerns over weakening Chinese demand and fewer anticipated U.S. rate cuts. Lower refinery output and slowing factory growth in China added pressure.</li>
<li>Natural Gas declined 2.44% to $2.717.</li>
<li>Gold was trading higher by 0.04% at $2,573.80, Silver gained 0.16% to $30.610, and Copper rose 1.6% to $4.1420.</li>
</ul>
US Futures at 05:30 AM ET
Dow futures decreased 0.44%, S&amp;P 500 futures were down 0.63%, and Nasdaq 100 futures fell 0.88%.
Forex at 05:30 AM ET
<ul>
<li>The U.S. Dollar Index declined 0.15% to 106.51, USD/JPY was down 0.60% at 155.30, and USD/AUD slid 0.25% to 1.5453.</li>
<li>The U.S. dollar hit near one-year highs after Fed Chair Powell&#8217;s hawkish comments boosted Treasury yields, pressuring equities. The dollar&#8217;s surge weighed on the euro, gold, and oil prices.</li>
</ul>
Image via Pexels

Asia

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Mixed; Fed's Hawkish Comments Boost Dollar - Global Markets Today While US Slept

HC Wainwright &amp; Co. analyst Robert Burns reiterates Cargo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGX#NASDAQ">CRGX</a>) with a Buy and maintains $33 price target.

CRGX

HC Wainwright & Co. Reiterates Buy on Cargo Therapeutics, Maintains $33 Price Target

HC Wainwright &amp; Co. analyst Matthew Caufield reiterates Kodiak Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOD#NASDAQ">KOD</a>) with a Neutral and maintains $3 price target.

HC Wainwright & Co. Reiterates Neutral on Kodiak Sciences, Maintains $3 Price Target

HC Wainwright &amp; Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBU#NASDAQ">CRBU</a>) with a Buy and maintains $9 price target.

CRBU

HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target

HC Wainwright &amp; Co. analyst Matthew Caufield reiterates DiaMedica Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMAC#NASDAQ">DMAC</a>) with a Buy and maintains $7 price target.

DMAC

HC Wainwright & Co. Reiterates Buy on DiaMedica Therapeutics, Maintains $7 Price Target

Needham analyst Joshua Reilly reiterates Digimarc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMRC#NASDAQ">DMRC</a>) with a Buy and maintains $40 price target.

DMRC

Needham Reiterates Buy on Digimarc, Maintains $40 Price Target

New Preferred Stock And Exchange Traded Debt IPOs, July 2024

DCOM

DCOMG

DCOMP

HIGH

MSPQL

MSTLW

NYMT

NYMTI

NYMTL

NYMTM

NYMTN

NYMTZ

OXLC

OXLCI

OXLCL

OXLCN

OXLCO

OXLCP

OXLCZ

TRIN

TRINI

TRINL

TRINZ

6.625% PRF PERPETUAL USD 25 - Dep Rep 1/1000 Ser Q

Comments

Noticias

Últimas noticias sobre (OTC:MSPQL) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL